BrainEye, a pioneering Australian health-tech company, is getting ready to launch in Indonesia, introducing its AI-powered, smartphone-based solution for brain function assessment. This milestone is supported by football legend and BrainEye Brand Ambassador Emmanuel Petit, 1998 FIFA World Cup and UEFA European Champion, who joins BrainEye to advocate for greater awareness of brain health and concussion safety in sports.
The recent event in Jakarta was held to introduce the app to the Indonesian market, presenting the BrainEye team, including its Chairman Clive Barrett, COO Steven Barrett, and its CSO Associate Professor Joanne Fielding, alongside Emmanuel Petit as the BrainEye Ambassador, and Lauren Adams, Australian Trade and Investment Commission (Austrade), representing the Australian government.
This event marks a major step forward in delivering accessible, real-time brain health monitoring to support Indonesia’s growing digital health transformation and commitment to preventive care.
The app is a powerful, low-cost brain health screening tool that delivers quick, accurate results in the palm of your hand. The app is more accessible and user-friendly than ever before, with no expensive hardware. In less than 40 seconds, a user is given a snapshot of their brain health and an indication of how their brain health is trending over time. With over 120,000 tests performed worldwide, BrainEye is a non-invasive, Class 1M medical device, which has been clinically measured and validated against gold-standard clinical devices.
BrainEye is applicable across diverse industries, including redefining sports safety, clinical neurology, mental wellness, and elder care. It also transforms concussion screening in sports with objective, data-driven results up to three times more reproducible than SCAT.
We were honored to be part of this important milestone, marking a major step in delivering accessible neuro health solutions and strengthening Australia-Indonesia collaboration in digital transformation and healthcare innovation.
